MLICM
TRNS icon

Metropolitan Life Insurance Company (MetLife)’s Transcat TRNS Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TRNS Stock Details TRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-467
Closed -$52K – 1949
2024
Q1 		$52K Hold
467
– – ﹤0.01% 1383
2023
Q4 		$51.1K Buy
467
+50
+12% +$4.81K ﹤0.01% 1439
2023
Q3 		$40.9K Hold
417
– – ﹤0.01% 1519
2023
Q2 		$35.6K Hold
417
– – ﹤0.01% 1629
2023
Q1 		$37.3K Hold
417
– – ﹤0.01% 1550
2022
Q4 		$29.6K Hold
417
– – ﹤0.01% 1798
2022
Q3 		$31.6K Hold
417
– – ﹤0.01% 1768
2022
Q2 		$23.7K Hold
417
– – ﹤0.01% 1961
2022
Q1 		$33.8K Sell
417
-1,181
-74% -$96K ﹤0.01% 1815
2021
Q4 		$148K Sell
1,598
-490
-23% -$41.3K ﹤0.01% 2232
2021
Q3 		$135K Hold
2,088
– – ﹤0.01% 2348
2021
Q2 		$118K Hold
2,088
– – ﹤0.01% 2507
2021
Q1 		$102K Buy
+2,088
New +$89.5K ﹤0.01% 2418
2020
Q2 		– Sell
-2,390
Closed -$63.3K – 2597
2020
Q1 		$63.3K Buy
+2,390
New +$71.7K ﹤0.01% 2301

Other funds holding TRNS

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BAM
Broadcrest Asset Management Winter Park, Florida $44.1M AUM 4.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TRNS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Transcat (TRNS) in Q2 2024, closing a stake of 467 shares — an estimated $52K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TRNS in Q1 2020 and held it in 14 quarters. The position peaked at $148K in Q4 2021. 147 funds tracked by Wall St. Rank hold TRNS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Transcat position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 467 Transcat shares in Q2 2024, an estimated $52K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Transcat in Q1 2020 and held it in 14 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Transcat position peaked at $148K in Q4 2021.
  • 147 funds tracked by Wall St. Rank held Transcat as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.